Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 2 | Mind Blowing Facts

NICE Agents? Trump Confirms Plan to Rename ICE While Moving Forward with Record Breaking US Deportation

President Trump proposes renaming ICE to NICE, amidst record deportations and political controversy. The rebrand aims to soften the agency's image during a contentious period in its history.

International Business Times UK

Trump backs changing ICE’s name to ‘NICE’ in Truth Social post

IN FULL

The Independent UK

Trump Sparks Controversy With Plan to Rebrand ICE as 'NICE' to 'Force' Media Outlets Into Calling Border Officers 'NICE Agents'

A viral claim about Trump allegedly rebranding ICE as 'NICE' has triggered controversy and an explosion of memes online, fueling debate over media language and political messaging.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

With ‘incompetence at every level’, Nantes are staring down the barrel at relegation

With 23 managerial appointments since Waldemar Kita bought Nantes in 2007, relegation now beckons for Les Canaris

The Guardian - UK

Trump wants to rename ICE as 'NICE', and the reason is...

A viral idea to rename a major US immigration agency has suddenly gained attention after Donald Trump threw his support behind it.

The Times of India

‘DO IT’: Donald Trump backs plan to rename ICE to ‘NICE’ to improve image of agents

Time to improve ICE's public image with a full rebrand.

We Got This Covered

Arsenal loanee Ethan Nwaneri sent stark Marseille warning: 'He has to give way more'

Gunners youngster has struggled for regular starts since heading to France in January

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Dozens of MPs oppose Streeting’s new power to say what NHS pays for drugs

Health secretary’s ‘power grab’ to override Nice comes amid growing concern move may be illegal and benefit big pharma

The Guardian - UK

‘Electric shock therapy for depression made me forget my wedding day’

About a third of people reported brain damage after electroconvulsive therapy, with many suffering memory loss, study found

The Independent UK

Predicting Canada’s 2026 World Cup Roster 50 Days From Kickoff

Canada could play up to five games on home soil this summer.

Sports Illustrated

PSG have the edge in the Ligue 1 title race but face seven matches in 23 days

PSG’s win against Nantes gives them a four-point lead on Lens, but now have a gruelling schedule to play through

The Guardian - UK

NHS approves new treatment for aggressive cancer that could triple life expectancy

Also known as Ziihera, the antibody treatment targets a protein called HER2, which stimulates tumour growth. It works by activating the immune system to eliminate cancer cells and reduces HER2 levels

The Independent UK

Lorient are climbing the Ligue 1 table but losing their manager is a risk

Bill Foley – who also owns Bournemouth – thinks he can do better than Olivier Pantaloni but he may prove mistaken

The Guardian - UK

Effect of ‘gamechanger’ Alzheimer’s drugs ‘trivial’, review concludes

Data assessed from 17 clinical trials of anti-amyloid drugs found no ‘meaningful effect’ on cognitive decline

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Warren Zaïre-Emery has made PSG’s dazzling midfield even better

Thierry Henry loves him. Didier Deschamps made him a France player at 17. And Luis Enrique says he is ‘spectacular’

Cycling News

Pays de la Loire Tour: Alexander Kamp sprints to first victory for three years on stage 3, moves into race lead

Dane beats Antoine L'Hote and Gabriele Bessega to the line in Sainte-Suzanne-et-Chammes from small group

Fortune

Amid the 'SaaSpocalypse,' CIOs and CTOs take a harder line with their vendors

As investors debate the threat that AI poses to enterprise software companies, CIOs are on the font lines of the changes affecting the industry.

International Business Times UK

NHS to Offer Weekly Injection That Reduces Heart Attack Risk by 20%—Who Gets It First?

The NHS is set to introduce Wegovy, a new weight-loss injection, to help reduce the risk of heart attacks and strokes in patients with cardiovascular disease and obesity.

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

NHS to roll out weight-loss jabs for patients at risk of repeat heart attacks

A weekly weight-loss injection could soon be offered on the NHS to help prevent heart attacks and strokes in high-risk patients

inkl

From Touch-Tone to Talk: The Evolution of Conversational AI IVR Systems

For decades, customers have endured the infamous “Press 1 for billing, Press 2 for support” menus—often called the dreaded phone tree. These rigid, touch-tone menus frustrated users, leading to abandoned calls, extended wait times, and unnecessary customer dissatisfaction. Despite advances in call center software technology, many legacy systems still rely…

The Guardian - UK

NHS England to offer weight-loss drugs to 1.2m people to reduce risk of heart attacks and strokes

People who are not obese but overweight and at risk of serious cardiovascular events eligible for weekly jabs

The Independent UK

More than one million people to get ‘life-changing’ weight loss drugs to prevent heart attacks and strokes

About 1.2 million people across England could benefit from the new guidance

The Independent UK

1m to get ‘life-changing’ weight loss drugs to prevent heart attacks and strokes

The NHS is expanding the number of people eligible for treatment.

Radio France Internationale

Lens play Angers with chance to ramp up Ligue 1 pressure on PSG

Second-placed Lens take on Angers on Friday night at the Stade Bollaert-Delelis with the chance to go two points clear of Paris Saint-Germain at the top of Ligue 1 for at least 24 hours.

The Independent UK

NHS watchdog to review evidence on two pioneering Alzheimer’s drugs

Donanemab and lecanemab were licensed for use in the UK in 2024 but were not made available on the NHS after Nice deemed their benefits “too small” to justify the cost

1 2 3 4 5

People

Khvicha Kvaratskhelia

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UEFA Champions League

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.